• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用1,2 - 二甲基 - 3 - 羟基吡啶 - 4 - 酮、1 - 羟基吡啶 - 2 - 酮和乙酰氧肟酸从单铁人血清转铁蛋白中去除铁。

Iron removal from monoferric human serum transferrins by 1, 2-dimethyl-3-hydroxypyridin-4-one, 1-hydroxypyridin-2-one and acetohydroxamic acid.

作者信息

Li Y, Harris W R

机构信息

Department of Chemistry, University of Missouri-St. Louis, St. Louis, MO 63121, USA.

出版信息

Biochim Biophys Acta. 1998 Sep 8;1387(1-2):89-102. doi: 10.1016/s0167-4838(98)00109-5.

DOI:10.1016/s0167-4838(98)00109-5
PMID:9748517
Abstract

The kinetics of iron removal from both forms of human serum monoferric transferrin by three ligands, 1, 2-dimethyl-3-hydroxypyridin-4-one (L1), 1-hydroxypyridin-2-one and acetohydroxamic acid, have been evaluated at pH 7.4 and 25.0 degreesC. In almost all cases the rate of iron removal follows simple saturation kinetics with respect to the ligand concentration. No spectroscopically distinct intermediates are observed during the iron removal reaction, which is consistent with a mechanism in which the rate-limiting step in iron removal is a protein conformational change. In the presence of chloride or perchlorate, most systems continue to follow simple saturation kinetics, but with significantly different kmax values. Chloride accelerates iron release from both transferrin binding sites, while perchlorate accelerates iron release from the C-terminal site but retards iron release from the N-terminal site. When the hydrochloride salt of L1 is used to prepare the L1 stock solution, the allosteric effect of the chloride produces a continuing increase in the rate of iron removal with increasing ligand concentration, so that one no longer observes simple saturation kinetics. A least squares fit of kobs vs. the ligand concentration for L1.HCl shows that the allosteric effect of the chloride not only enhances the first-order term for iron removal but also doubles the apparent kmax for the saturation term. This supports the view that allosteric binding of anionic ligands contributes to the observed variation in kmax among different ligands. A detailed description of this allosteric effect is not yet possible because the effect varies significantly from system to system, depending upon the specific anion that is binding at the allosteric site, the ligand that is used to remove the iron, and the transferrin lobe from which iron is removed.

摘要

在pH 7.4和25.0℃条件下,评估了三种配体1,2 - 二甲基 - 3 - 羟基吡啶 - 4 - 酮(L1)、1 - 羟基吡啶 - 2 - 酮和乙酰氧肟酸从两种形式的人血清单铁转铁蛋白中去除铁的动力学。在几乎所有情况下,铁去除速率相对于配体浓度遵循简单的饱和动力学。在铁去除反应过程中未观察到光谱上不同的中间体,这与铁去除的限速步骤是蛋白质构象变化的机制一致。在存在氯离子或高氯酸根离子的情况下,大多数体系继续遵循简单的饱和动力学,但具有显著不同的kmax值。氯离子加速了铁从两个转铁蛋白结合位点的释放,而高氯酸根离子加速了铁从C端位点的释放,但减缓了铁从N端位点的释放。当使用L1的盐酸盐制备L1储备溶液时,氯离子的变构效应导致随着配体浓度增加铁去除速率持续增加,因此不再观察到简单的饱和动力学。L1.HCl的观测速率常数kobs与配体浓度的最小二乘拟合表明,氯离子的变构效应不仅增强了铁去除的一级项,还使饱和项的表观kmax增加了一倍。这支持了阴离子配体的变构结合导致不同配体之间观察到的kmax变化的观点。由于这种变构效应因体系而异,取决于在变构位点结合的特定阴离子、用于去除铁的配体以及去除铁的转铁蛋白叶,因此目前还无法对这种变构效应进行详细描述。

相似文献

1
Iron removal from monoferric human serum transferrins by 1, 2-dimethyl-3-hydroxypyridin-4-one, 1-hydroxypyridin-2-one and acetohydroxamic acid.利用1,2 - 二甲基 - 3 - 羟基吡啶 - 4 - 酮、1 - 羟基吡啶 - 2 - 酮和乙酰氧肟酸从单铁人血清转铁蛋白中去除铁。
Biochim Biophys Acta. 1998 Sep 8;1387(1-2):89-102. doi: 10.1016/s0167-4838(98)00109-5.
2
Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.重组及定点突变N端叶半转铁蛋白中铁和铝去除的动力学研究
Biochemistry. 1998 Oct 6;37(40):14157-66. doi: 10.1021/bi9810454.
3
Allosteric effects of sulfonate anions on the rates of iron release from serum transferrin.磺酸盐阴离子对血清转铁蛋白中铁释放速率的变构效应。
J Inorg Biochem. 2011 Sep;105(9):1148-55. doi: 10.1016/j.jinorgbio.2011.05.021. Epub 2011 Jun 12.
4
Release of iron from transferrin by phosphonocarboxylate and diphosphonate chelating agents.通过膦酰基羧酸盐和二膦酸盐螯合剂从转铁蛋白中释放铁。
J Inorg Biochem. 2004 Nov;98(11):1824-36. doi: 10.1016/j.jinorgbio.2004.08.008.
5
The anion requirement for iron release from transferrin is preserved in the receptor-transferrin complex.转铁蛋白释放铁所需的阴离子在受体 - 转铁蛋白复合物中得以保留。
Biochemistry. 1993 Aug 17;32(32):8162-7. doi: 10.1021/bi00083a016.
6
Release of iron from C-terminal monoferric transferrin to phosphate and pyrophosphate at pH 5.5 proceeds through two pathways.在pH 5.5条件下,C端单铁转铁蛋白中的铁释放至磷酸盐和焦磷酸盐的过程通过两条途径进行。
J Inorg Biochem. 1995 Jan;57(1):11-21. doi: 10.1016/0162-0134(94)00009-y.
7
Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates.快速生物铁螯合剂:多齿羟基吡啶酮从人双铁转铁蛋白中去除铁的动力学
J Biol Inorg Chem. 2000 Oct;5(5):634-41. doi: 10.1007/s007750000149.
8
Large cooperativity in the removal of iron from transferrin at physiological temperature and chloride ion concentration.在生理温度和氯离子浓度下,转铁蛋白去除铁的过程中存在较大的协同性。
J Biol Inorg Chem. 2004 Dec;9(8):936-44. doi: 10.1007/s00775-004-0592-6. Epub 2004 Oct 29.
9
Site-specific rate constants for iron acquisition from transferrin by the Aspergillus fumigatus siderophores N',N'',N'''-triacetylfusarinine C and ferricrocin.烟曲霉铁载体N',N'',N'''-三乙酰铁载体C和铁载体从转铁蛋白获取铁的位点特异性速率常数。
J Biol Inorg Chem. 2005 May;10(3):211-20. doi: 10.1007/s00775-005-0630-z. Epub 2005 Mar 16.
10
Effect of ligand structure on the pathways for iron release from human serum transferrin.配体结构对人血清转铁蛋白释放铁的途径的影响。
Inorg Chem. 2005 Jul 11;44(14):5183-91. doi: 10.1021/ic050411m.

引用本文的文献

1
The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases.去铁酮在将地中海贫血从致命疾病转变为慢性疾病过程中所起的关键作用及其在非铁过载疾病中重新应用面临的挑战
Pharmaceuticals (Basel). 2023 Jul 18;16(7):1016. doi: 10.3390/ph16071016.
2
Electrostatic effects control the stability and iron release kinetics of ovotransferrin.静电效应控制着卵转铁蛋白的稳定性和铁释放动力学。
J Biol Inorg Chem. 2014 Aug;19(6):1009-24. doi: 10.1007/s00775-014-1145-2. Epub 2014 May 22.
3
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
环吡酮胺和去铁酮抑制 HIV-1 基因表达,这两种药物可防止真核起始因子 5A 的超氨化。
Retrovirology. 2009 Oct 13;6:90. doi: 10.1186/1742-4690-6-90.
4
Large cooperativity in the removal of iron from transferrin at physiological temperature and chloride ion concentration.在生理温度和氯离子浓度下,转铁蛋白去除铁的过程中存在较大的协同性。
J Biol Inorg Chem. 2004 Dec;9(8):936-44. doi: 10.1007/s00775-004-0592-6. Epub 2004 Oct 29.
5
The chloride effect is related to anion binding in determining the rate of iron release from the human transferrin N-lobe.氯离子效应与阴离子结合有关,它决定了铁从人转铁蛋白N端叶释放的速率。
Biochem J. 2000 Sep 15;350 Pt 3(Pt 3):909-15.